COIN vs EBS
Coinbase Global Inc (COIN) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Coinbase Global Inc (COIN) is a financial data & stock exchanges company listed on US. It is led by Brian Armstrong.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported COIN revenue for 2025-12-31 was $7.18B. Net income was $1.26B. Revenue was up 9.4% from 2024-12-31 to 2025-12-31. COIN currently screens at market cap $45.84B and trailing P/E 64.2.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
COIN currently screens at market cap $45.84B and trailing P/E 64.2. EBS currently screens at market cap $416.4M.
Not investment advice. Open the COIN and EBS stock pages for the full models.
Not investment advice.